Overview

Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias

Status:
Unknown status

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

Summary

The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were assessed with the use of an implanted monitoring device (IMD).

Phase:

Phase 2

Details

Lead Sponsor:

Meshalkin Research Institute of Pathology of Circulation

Treatments:

Botulinum Toxins